Shenzhen Hepalink Pharmaceutical Group Co. Ltd. Held Extraordinary General Meeting
I'm PortAI, I can summarize articles.
Shenzhen Hepalink Pharmaceutical Group Co. Ltd. held its first extraordinary general meeting of 2025 on December 16. Shareholders approved the abolition of the Supervisory Committee, amendments to the Articles, changes to procedural rules, internal governance measures, and elected an independent non-executive director.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments